Option Care Health, Inc. $OPCH Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. trimmed its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 2.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,552,851 shares of the company’s stock after selling 56,854 shares during the quarter. Charles Schwab Investment Management Inc. owned 1.57% of Option Care Health worth $82,917,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Fuller & Thaler Asset Management Inc. boosted its holdings in Option Care Health by 30.8% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company’s stock worth $146,947,000 after buying an additional 989,048 shares in the last quarter. Durable Capital Partners LP acquired a new position in shares of Option Care Health in the 1st quarter worth $122,905,000. Jennison Associates LLC raised its position in shares of Option Care Health by 145.6% during the second quarter. Jennison Associates LLC now owns 2,138,248 shares of the company’s stock worth $69,450,000 after purchasing an additional 1,267,660 shares during the period. Nuveen LLC purchased a new stake in shares of Option Care Health during the first quarter valued at $70,965,000. Finally, The Manufacturers Life Insurance Company boosted its position in shares of Option Care Health by 8.8% in the 1st quarter. The Manufacturers Life Insurance Company now owns 1,651,489 shares of the company’s stock valued at $57,720,000 after purchasing an additional 133,497 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Insiders Place Their Bets

In other news, Director Norman L. Wright purchased 3,411 shares of the business’s stock in a transaction dated Tuesday, September 9th. The stock was bought at an average cost of $29.31 per share, with a total value of $99,976.41. Following the purchase, the director directly owned 15,501 shares of the company’s stock, valued at approximately $454,334.31. This trade represents a 28.21% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of Option Care Health stock in a transaction dated Monday, November 3rd. The shares were purchased at an average price of $25.98 per share, with a total value of $987,240.00. Following the completion of the acquisition, the director owned 413,390 shares in the company, valued at $10,739,872.20. The trade was a 10.12% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.64% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms have commented on OPCH. Morgan Stanley started coverage on shares of Option Care Health in a research note on Friday, October 17th. They set an “overweight” rating and a $35.00 price objective for the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Option Care Health in a research note on Tuesday. Wall Street Zen cut shares of Option Care Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. JMP Securities set a $36.00 target price on Option Care Health in a report on Friday, October 31st. Finally, TD Cowen lowered their price target on Option Care Health from $30.00 to $27.00 and set a “hold” rating on the stock in a report on Monday, November 3rd. Nine equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $35.67.

Option Care Health Stock Up 0.3%

OPCH stock opened at $31.10 on Friday. The company has a 50 day moving average of $27.98 and a two-hundred day moving average of $29.40. The company has a market cap of $4.94 billion, a price-to-earnings ratio of 24.88, a PEG ratio of 1.74 and a beta of 0.88. Option Care Health, Inc. has a 12-month low of $22.29 and a 12-month high of $35.53. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.